Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity.

Tsoutsou, Pelagia G; Zaman, Khalil; Martin Lluesma, Silvia; Cagnon, Laurene; Kandalaft, Lana; Vozenin, Marie-Catherine

Tsoutsou, Pelagia G; Zaman, Khalil; Martin Lluesma, Silvia; Cagnon, Laurene; Kandalaft, Lana; Vozenin, Marie-Catherine.

Afiliación

Tsoutsou PG; Division of Oncology, Radio-oncology Department, Vaudois University Hospital Centre (CHUV), Lausanne, Switzerland.
Zaman K; Radio-Oncology Research Laboratory, Vaudois University Hospital Centre (CHUV), Epalinges, Switzerland.
Martin Lluesma S; Radiation Oncology Department, Hôpital Neuchâtelois, La Chaux-de-Fonds, Switzerland.
Cagnon L; Department of Oncology, Breast Center, Vaudois University Hospital Centre (CHUV), Lausanne, Switzerland.
Kandalaft L; Department of Oncology, Center of Experimental Therapeutics, Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland.
Vozenin MC; Department of Oncology, Center of Experimental Therapeutics, Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland.

Front Oncol ; 8: 609, 2018.

Article en En | MEDLINE | ID: mdl-30619749

Palabras clave

TILs; breast cancer; immunotherapy; radiotherapy; subtypes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2018 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google